Form 4 holding
Director
ChromaDex Corp.
- Security class
- Common Stock
- Shares / value
- 2,075,052
- Estimated value
- $12,840,629
- Report date
- 13 Dec 2024
- Price
- $6.19
- Ownership
- By Black Sheep, FLP
Frank L. Jaksch Jr. - Director at Niagen Bioscience, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- NAGE on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Frank L. Jaksch Jr. since 06 Oct 2025
Reported holdings for Frank L. Jaksch Jr. in Niagen Bioscience, Inc.
Form 4 holding
Director
ChromaDex Corp.
- Security class
- Common Stock
- Shares / value
- 244,179
- Estimated value
- $1,511,004
- Report date
- 13 Dec 2024
- Price
- $6.19
- Ownership
- Direct
Form 4 holding
Director
Niagen Bioscience, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 31,746
- Estimated value
- Report date
- 24 Jun 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
ChromaDex Corp.
- Security class
- Employee Stock Options (right to buy)
- Shares / value
- 0
- Estimated value
- Report date
- 13 Dec 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Frank L. Jaksch Jr. in Niagen Bioscience, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.